Utilising the extensive range of data assets exclusively available to IQVIA, combined with our market leading expertise, we are able to support the NHS meet the challenge of delivering high quality, efficient and cost effective healthcare by identifying actionable insight and realising the value in data.
Learn MoreWe believe in the UK’s potential to become a global leader in the life sciences sector, and our investments announced in the 2018 Second Life Sciences Sector Deal further support the UK Government and the industry’s aim to make that potential a reality.
Learn MoreWe are committed to providing solutions that inform and enable all stakeholders across UK healthcare, to innovate with confidence, maximise opportunities, and, ultimately, drive human health outcomes forward.
Learn More
IQVIA’s Pharmacy Communications offers pharma companies a simple and cost-effective channel to communicate product changes, updates and patient advice directly to patients via pharmacists.
Learn MoreExplore our library of resources spanning the healthcare & life science ecosystem on the latest topics, trends, and market developments that matter to you.
Learn More
The HMSL studies focus on the treatment and care management trends for a variety of conditions and therapies.
These are bimonthly or quarterly studies and are based on a representative panel of secondary care medical specialists from outpatient clinics. Thanks to this valuable collaboration, the HMSL studies offer insights into:
Once or twice within the quarter, our collaborating medical specialists are asked to complete anonymous online questionnaires about their consultations.
The questionnaires aim to understand:
These questionnaires comply with the requirements of medical confidentiality and the GDPR.
